Trials / Completed
CompletedNCT05127746
Phase 1 Clinical Trial of DA-5207 in Healthy Adults
An Open-label, Randomized, Cross-over, Multiple Dose, Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of DA-5207 Transdermal Delivery System in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics and pharmacodynamics of DA-5207 transdermal delivery system in healthy adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aricept 5mg Tablet | 1 tablet once daily |
| DRUG | Aricept 10mg Tablet | 1 tablet once daily |
| DRUG | DA-5207 A | 1 patch once weekly |
| DRUG | DA-5207 B | 1 patch once weekly |
Timeline
- Start date
- 2021-11-25
- Primary completion
- 2022-12-13
- Completion
- 2022-12-13
- First posted
- 2021-11-19
- Last updated
- 2023-04-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05127746. Inclusion in this directory is not an endorsement.